A novel patient-derived organoid model for triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy for screening personalized drugs.
文献类型：期刊论文
| 作者 | Liu, Feiyang ; Ma, Dandan; Liu, Qingsong; Qi, Xiaowei
|
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2022-06-01 |
| 卷号 | 40 |
| ISSN号 | 0732-183X |
| 资助项目 | Presidential Foundation of Hefei Institutes of Physical Science, Chinese Academy of Sciences, China |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| WOS记录号 | WOS:000863680302526 |
| 资助机构 | Presidential Foundation of Hefei Institutes of Physical Science, Chinese Academy of Sciences, China |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/129813]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Army Med Univ, Sounthwest Hosp, Dept Breast & Thyroid Surg, Chongqing, Peoples R China 2.Chinese Acad Sci, Hefei Inst Phys Sci, Inst Hlth & Med Technol, Anhui Prov Key Lab Med Phys & Technol, Hefei, Peoples R China |
| 推荐引用方式 GB/T 7714 | Liu, Feiyang,Ma, Dandan,Liu, Qingsong,et al. A novel patient-derived organoid model for triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy for screening personalized drugs.[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40. |
| APA | Liu, Feiyang,Ma, Dandan,Liu, Qingsong,&Qi, Xiaowei.(2022).A novel patient-derived organoid model for triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy for screening personalized drugs..JOURNAL OF CLINICAL ONCOLOGY,40. |
| MLA | Liu, Feiyang,et al."A novel patient-derived organoid model for triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy for screening personalized drugs.".JOURNAL OF CLINICAL ONCOLOGY 40(2022). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。